The ampicillin resistance of clinical isolates of Shigella sonnei is due to ,-lactamase production. 
The ampicillin resistance of clinical isolates of Shigella sonnei is due to ,-lactamase production. Two kinds of resistance are found: low level, nontransmissible; and high level, tranmissible. The nontransmissible type of resistance results from a chromosomal mutation which increases the production of a ,B-lactamase that hydrolyses cephalosporins relatively rapidly and gives cephalothin resistance. The transmissible type of resistance is due to an R factor mediating the synthesis of a different ,8-lactamase that does not significantly hydrolyze cephalosporins or confer cephalothin resistance. One clinical isolate is shown to possess simultaneously both these mechanisms of ampicillin resistance.
Among strains of Shigella sonnei isolated in Auckland in 1973, 23 out of 24 were resistant to ampicillin. This is similar to the situation in London, where 94% of S. sonnei isolates have been found to be ampicillin resistant (6) . In Britain, previous studies (5, 8) have shown that such strains of S. sonnei exhibit marked differences in their level of resistance to ampicillin. Strains with high-level resistance (resistant to >500 ug of ampicillin per ml of medium) are usually capable of transferring ampicillin resistance to Escherichia coli, whereas R factors have not been detected in strains exhibiting the lower levels of resistance (resistant to <500 gg of ampicillin per ml of medium) (8, 6) .
We have found that the same is true of S. sonnei isolated in New Zealand. This paper describes experiments elucidating the nature of the high-and low-level types of ampicillin resistance and explains differences between these strains in their pattern of resistance to various penicillins and cephalosporins.
MATERIALS AND METHODS
Strains of S. sonnei. Twenty-four representative clinical isolates of S. sonnei from Auckland, New Zealand, were studied. Initial susceptibility tests were made with disks containing 25 gg of ampicillin and 30 gg of cephalothin. All but one of the strains were resistant to both these antibiotics; that strain, susceptible to both, was called strain 1. Susceptibility tests were also made with Oxoid Multodisks to streptomycin (Sm), tetracycline (Tc), chloramphenicol (Cm), kanamycin (Km), gentamicin (Gm), sulphonamides (Su), and trimethoprim (Tp).
Strains of E. coli. Ampicillin-resistant mutants of E. coli, strains 214T (9) and K-12 D3 (1), were used for comparison with strains of S. sonnei. E. coli K-12 J53-1 (F-pro met nalr) (3) was used as recipient for R factors from S. sonnei. Levels of resistance. The minimal inhibitory concentrations (MIC) were measured as follows. Overnight broth cultures were so diluted that the inoculum delivered by a multiple-inoculating apparatus yielded about 25 separate colonies on drug-free medium. Duplicate plates were prepared, each containing 20 ml of Oxoid direct sensitivity test medium (CM 261), without antibiotic and with serial twofold dilutions of freshly prepared solutions of the following drugs: ampicillin, carbenicillin, cephaloridine, and cephalothin. Each plate was inoculated with every strain under test, using the multiple inoculator. The MIC of each drug was recorded as the lowest concentration that prevented all visible growth from the standardized inoculum.
Selection of an ampicillin-resistant mutant of susceptible S. sonnei. A susceptible strain of S. sonnei (strain 1) was grown at 37 C with aeration, overnight, in 1Y ml of nutrient broth (Oxoid no. 2, CM67). The whole of this culture was added to 100 ml of broth, with ampicillin added to a final concentration of 100 jig/ml. This culture was incubated with aeration for 24 h, when a loopful was streaked on a MacConkey agar (Oxoid CM 7b) plate containing 50 1g of ampicillin per ml of medium. A single colony isolate from this plate was identified by biochemical and serological tests as S. sonnei and shown to be resistant, by the disk test, to ampicillin and cephalothin. It was designated S. sonnei strain 1A.
Transfer of resistance. S. sonnei strains resistant to ampicillin and cephalothin were each mixed in broth culture with E. coli K-12 J53-1 (which is resistant to nalidixic acid) and incubated without aeration ovemight at 37 C. The mixture was plated on MacConkey agar in which was incorporated 25 Mg of ampicillin and 50 yg of nalidixic acid per ml. Neither donor nor recipient strain, in pure culture, would grow VOL. 6, 1974 on this medium. If lactose-fermenting colonies developed on this selection plate, they were, purified by restreaking on MacConkey agar incorporating 25Mug of ampicillin per ml of medium (without nalidiuic acid) and identified as E. coli K-12 by biochemical reactions and nutritional requirements. Such recipient bacteria were then tested for susceptibility to other antibiotics by the disk method. Where no transfer of resistance was demonstrated using ampicillin in the selection plates, the test was repeated with 25 Mg of cephalothin per ml of medium instead of ampicillin.
When ampicillin resistance was transferred from S. sonnei to E. coli, the resultant R+ J53-1 strain was used as a donor, with S. sonnei 1 as recipient. Selection was made on minimal salts agar (2) supple7 mented with glucose, nicotinic acid, and ampicillin. The J53-1R+ donor would not grow on this medium because it requires proline and methionine. S. sonnei 1 would grow only if it acquired ampicillin resistance during growth in the mixed culture. The R+ S. sonnei 1 colonies were restreaked on MacConkey agar incorporating ampicillin and then identified and tested for susceptibility to other antibiotics by the disk method.
Estimation and characterization of ,-lactamases. The bacteria were cultivated and fi-lactamase preparations were made as described previously (7). The #-lactamase activities were estimated using the hydroxylamine assay (4) with benzylpenicillin, ampicillin, cephaloridine, and oxacillin as substrates. Absolute levels of fi-lactamase activity were determined by using as units of activity that amount of enzyme catalyzing the hydrolysis of 1 Mmol of substrate per min at 30 C in 25 mM phosphate buffer, pH 7.4. In practice, milliunits were used where 1 mU = 0.001 U. The effects of 0.5 mM parachlormercuribenzoate and 100 mM sodium chloride were tested against all fi-lactamases studied as described previously (7) .
RESULTS
Naturally occurring S. sonnei strains. Table 1 shows the resistance patterns of the S. sormei strains.
Transfer of resistance. The 23 strains of S. sonnei resistant to ampicillin and cephalothin were tested for their ability to transfer resistance to E. coli J53-1. Only one isolate, strain 3, transferred ampicillin resistance; the others did not transfer either ampicillin or cephalothin resistance ( Table 1 ). The R factor from S. sonnei 3 was termed R-DB1.
MIC. MICs of ampicillin were measured for all the 23 ampicillin-resistant, naturally, occurring strains of S. sonnei. Only one had an MIC of 500 ,g of ampicillin per ml; this was strain 3, which was also the only strain that transferred ampioillin resistance. The ampicillin resistance, and the other was S. sonnei 1, into which R-DB1 had been transferred, termed S. sonnei 1 (R-DB1). In addition, for comparative purposes four strains of E. coli were included. Two of these, strains D3 and 214T, were ampicillin-resistant mutants of E. coli, whereas strain J53-1 represented the ampicillin-susceptible parent of D3, and strain J53-1(R-DB1) was E. coli harboring the R factor from S. sonnei 3. The MICs of the susceptible E. coli J53-1 and the naturally occurring susceptible S. sonnei 1 were similar. E. coli D3 and 214T and S. sonnei 1A and 2 were similar in respect to their MICs. None of these four strains transfer ampicillin resistance.
Regarding the R+ strains, E. coli J53-1(R-DB1) and S. sonnei 1 (R-DB1) were alike in their MICs, but they differed from S. sonnei 3, which was the original host for this R factor ( Table 2 ). The fact that S. sonnei 3 was more resistant to the cephalosporins than E. coli J53-1 (R-DB1) or S. sonnei 1 (R-DB1) suggests that the R factor did not carry all the genetic information for resistance to f,-lactam antibiotics possessed by this highly resistant clinical isolate.
B-lactamase activities. The strains used for the MIC determinations (Table 2) were examined for ,8-lactamase activity. The results (Table 3 , lines [1] [2] [3] [4] [5] show that despite differences in the absolute levels of ,8-lactamase activity against benzylpenicillin, five organisms produced enzymes indistinguishable from one another in their substrate specificity. Substrate specificity is defined as the rates of hydrolysis of cephaloridine, ampicillin, and oxacillin relative to that of benzylpenicillin. The enzymes from these five organisms hydrolyzed cephaloridine at about three times the rate of hydrolysis of benzylpenicillin, hydrolyzed ampicillin relatively slowly, and oxacillin not at all. It should be noted that the ampicillin-susceptible parent strain of D3, i.e., E. coli K-12, produces an insignificant level of,-lactamase (7). Table 3 (lines 6 and 7) shows that the enzymes from the two R+ strains, E. coli J53-1(R-DB1) and S. sonnei l(R-DB1), were similar in absolute levels of activity and in substrate specificity where ampicillin was hydrolyzed slightly more rapidly and cephaloridine slightly less rapidly than benzylpenicillin. Both these ,-lactamases had a low but significant activity against oxacillin, about 5% of the rate observed with benzylpenicillin. The ,8-lactamase mediated by this R factor hence resembles in every respect that mediated by Ri (7). Only one strain remains, S. sonnei 3; its absolute level of f-lactamase activity was the highest and its substrate specificity did not resemble that of any of the other strains studied (Table 3 , line 8). However, since (i) this strain was known to harbor the R factor R-DB1, (ii) the ,B-lactamase mediated by R-DB1 had a significant rate of hydrolysis of oxacillin, whereas (iii) the nontransferable ,@-lactamases did not attack this substrate, it was possible to calculate from the oxacillin rate how much,-lactamase activity could be attributed to that of the R factor. When these calculations were made (Table 3 , lines 9 and 10) it was seen that the residual (nontransferable) ,-lactamase of S. sonnei 3 had a substrate specificity indistinguishable from that of S. sonnei 1, 1A, and 2, and E. coli D3 and 214T (compare lines [1] [2] [3] [4] [5] with line 10). In on October 16, 2017 by guest http://aac.asm.org/ Downloaded from addition, such calculations allow us to conclude that R-DB1 mediates a ,8-lactamase of similar substrate specificity in all three strains, i.e., E. coli J53-1(R-DB1), S. sonnei 1(R-DB1), and S. sonnei 3 (see Table 3 , lines 6, 7, and 9). Moreover, as the level of,-lactamase activity mediated by R-DB1 was 86 and 146 mU in the two strains of S. sonnei, and 100 mU in E. coli, it can be concluded that the expression of this enzyme was similar in both genera. When compared with E. coli, some, but not all, species of gram-negative bacteria exhibit an impaired expression of R factor-mediated ,B-lactamases (4, 10) .
The ,B-lactamase preparations in Table 3 were tested for susceptibility to parachlormercuribenzoate and sodium chloride as outlined; neither reagent had a significant effect on any ,-lactamase.
DISCUSSION
The strains of S. sonnei from New Zealand resembled those studied in London in that the great majority were ampicillin resistant (6) . Two types of resistance were observed: high level, transmissible; and low level, nontransmissible. As found in England (8, 5) , strains with the latter type of resistance were preponderant. In our studies the MICs for both types of S. sonnei were slightly lower than those reported by Scrimgeour (8) Taking a fully susceptible S. sonnei strain, we have constructed two different kinds of resistant variants (i) by selecting an ampicillin-resistant mutant and (ii) by introducing an R factor. These laboratory strains have enabled us to elucidate the nature of the different types of ampicillin resistance found in clinical isolates of S. sonnei.
Both types of resistance are associated with the production of,B-lactamase. The more common type of resistant strain exhibited a ,8-lactamase activity similar in level and in substrate specificity to the ampicillin-resistant mutant of S. sonnei selected in the laboratory. Such ,B-lactamases were indistinguishable in all respects from those produced by two strains of E. coli (D3 and 214T) where the f,-lactamase genes are known to be on the chromosome. Both these strains of E. coli exhibited low levels of f-lactamase activity before mutating to produce higher levels of,-lactamase and so become ampicillin resistant (1, 9) . The ampicillin-susceptible strain of S. sonnei studied here also produced a low level of fB-lactamase (Table 3 , ling 1), whereas its ampicillin-resistant mutant produced higher levels of a similar enzyme (Table   3 , line 3). Judging from the predominance of these latter strains both in England and in New Zealand, the frequency of such a mutational event must be high relative to the equivalent event in E. coli. Hence, it would seem that a chromosomal mutation causing derepression of ,B-lactamase synthesis, analogous to that reported in E. coli (1, 9) , is responsible for the low-level, nontransmissible type of ampicillin resistance found, not only in laboratory-selected, but also in clinically isolated strains of S. sonnei.
Among 23 ampicillin-resistant strains of S. sonnei we found only one which would transfer ampicillin resistance. This strain was highly resistant to ampicillin because it produced simultaneously two different f,-lactamases, one mediated by the R factor and the other by the chromosome.
Resistance to cephalothin correlated well with the chromosomal type of ,8-lactamase in both S. sonnei and E. coli. However, no culture was highly resistant to cephaloridine, despite the production of enzymes capable of the rapid inactivation of this antibiotic.
